BBC News

PCOS name change 'more representative of condition'

PCOS name change 'more representative of condition'

New Terminology for PCOS Aims to Reflect Full-Body Impact

Health experts in Jersey are advocating for a terminology shift regarding Polycystic Ovary Syndrome (PCOS), arguing that the new designation better captures the nature of a metabolic disorder affecting over 170 million women worldwide. The condition has officially been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). According to the International PCOS Network, which implemented the change on May 12, the update is intended to enhance public understanding, facilitate earlier diagnosis, and improve treatment outcomes.

Jessica Pinel, a nutritionist and chair of PCOS Jersey, emphasized that the previous acronym created a misleading perception. "The term PCOS limited the condition to having an effect on women's ovaries, whereas we know that it is a full-body condition," Pinel explained. She noted that the disorder involves elevated male hormone levels and can manifest through symptoms such as irregular menstruation and weight gain, as outlined by the NHS.

Pinel, who was diagnosed with the condition three years ago following a costly treatment journey exceeding £3,000, highlighted the vast spectrum of experiences among patients. "There is such a diverse array of symptoms which has such an impact on their day-to-day lives," she observed. These symptoms range from fatigue, unwanted hair growth, and acne to brain fog, irregular cycles, and infertility. Pinel expressed hope that the rebranding would encourage more women to seek appropriate support for this complex array of issues, acknowledging that the condition affects individuals in unique ways.

A significant concern for Pinel is the prevalence of misinformation. She stressed that education should not rest solely on patients, particularly given the abundance of unverified content on platforms like TikTok, Instagram, and Facebook. This warning is underscored by a 2024 BBC investigation which revealed influencers marketing fraudulent cures for PCOS. Consequently, Pinel advises individuals suspecting they have the condition to consult professionals and emphasizes the importance of persistence in diagnosis. "In terms of diagnosis, you are always entitled to a second opinion," she said. Recalling her own struggles, she noted, "I wasn't diagnosed the first few times... I sought out a secondary opinion because I know my body. If you feel like you're not being seen or heard, then please go and seek that second opinion because you deserve it."

Medical professionals are also calling for a broader perspective on the disorder. Dr. Jessica Langtree-Marsh, a Jersey GP, described PCOS/PMOS as "hugely under-researched and hugely misunderstood." She criticized the current medical approach, stating, "We see it as just simply: 'Come back when you want to have a baby and we'll fix it then.' Actually, we need to look at this as a lifespan condition." Dr. Langtree-Marsh advocates for early diagnosis and education, hoping the name change will drive a shift in treatment strategies. Rather than relying exclusively on contraceptive pills, she suggests incorporating metabolic medications to better combat the condition.

The historical context of the original name also informs the change. Dr. Langtree-Marsh explained that PCOS was identified 70 years ago by male surgeons Dr. Irving Stein and Dr. Michael Leventhal. They originally termed it Stein-Leventhal Syndrome after observing specific ovarian appearances in women with absent periods. The name was later changed to PCOS, which Dr. Langtree-Marsh argues incorrectly implied the issue was confined to the ovaries. "The rebranded PMOS is trying to appreciate that it affects women more generally rather than just the ovaries, so that it's a whole body condition," she said. While acknowledging the new name "doesn't exactly roll off the tongue," she believes it successfully moves the definition away from a narrow focus.

The government has confirmed that a women's health strategy, mandated by the Government Plan, is scheduled for publication later this year.


Source: BBC News Generated at: 2026-05-26 05:27:03 UTC

Related Articles

Only the Right Tests Can Stop This Ebola Outbreak. Congo Has Hardly Any.
New York Times

Only the Right Tests Can Stop This Ebola Outbreak. Congo Has Hardly Any.

Congo’s severe shortage of Ebola diagnostic tests forces symptomatic patients to share isolation spaces, hindering outbr...

'I've requested a full hysterectomy'
BBC News

'I've requested a full hysterectomy'

The author requests a full hysterectomy, likely for endometriosis management. View the full episode on BBC iPlayer.

'Why I'm showing my hernia online'
BBC News

'Why I'm showing my hernia online'

The provided text contains unrelated Derbyshire news snippets and does not explain why Alan Graves is showing his hernia...

Emma Barnett: We can't ignore this disease that leaves one in 10 women like me in agony
BBC News

Emma Barnett: We can't ignore this disease that leaves one in 10 women like me in agony

Emma Barnett highlights endometriosis as a silent medical emergency affecting one in ten women, illustrated by Chloe’s d...

Daily pill doubles survival time for pancreatic cancer patients
BBC News

Daily pill doubles survival time for pancreatic cancer patients

A new daily drug, daraxonrasib, nearly doubles survival time for advanced pancreatic cancer patients by targeting the KR...

Checks reveal young women with deadly 'silent' heart risk
BBC News

Checks reveal young women with deadly 'silent' heart risk

UK screenings reveal young women face hidden sudden cardiac death risks, prompting debate on mandatory checks despite di...